Lixil Group Valuation

JSGRY Stock  USD 21.85  0.48  2.15%   
At this time, the firm appears to be overvalued. Lixil Group Corp secures a last-minute Real Value of $18.75 per share. The latest price of the firm is $21.85. Our model forecasts the value of Lixil Group Corp from analyzing the firm fundamentals such as Return On Equity of 0.0349, profit margin of 0.01 %, and Current Valuation of 7.89 B as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
21.85
Please note that Lixil Group's price fluctuation is very steady at this time. Calculation of the real value of Lixil Group Corp is based on 3 months time horizon. Increasing Lixil Group's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Lixil Group is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Lixil Pink Sheet. However, Lixil Group's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  21.85 Real  18.75 Hype  21.85
The intrinsic value of Lixil Group's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Lixil Group's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
18.75
Real Value
24.04
Upside
Estimating the potential upside or downside of Lixil Group Corp helps investors to forecast how Lixil pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Lixil Group more accurately as focusing exclusively on Lixil Group's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
20.5321.8523.17
Details

Lixil Group Total Value Analysis

Lixil Group Corp is currently projected to have takeover price of 7.89 B with market capitalization of 4.61 B, debt of 337.51 B, and cash on hands of 126.99 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Lixil Group fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
7.89 B
4.61 B
337.51 B
126.99 B

Lixil Group Investor Information

The company has price-to-book ratio of 0.94. Some equities with similar Price to Book (P/B) outperform the market in the long run. Lixil Group Corp last dividend was issued on the 29th of September 2022. Based on the analysis of Lixil Group's profitability, liquidity, and operating efficiency, Lixil Group Corp is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.

Lixil Group Asset Utilization

The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Lixil suggests not a very effective usage of assets in December.

Lixil Group Ownership Allocation

Lixil Group Corp maintains a total of 143.53 Million outstanding shares. Roughly 99.99 % of Lixil Group outstanding shares are held by general public with 0.007 % by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Lixil Group Profitability Analysis

The company reported the revenue of 1.43 T. Net Income was 48.6 B with profit before overhead, payroll, taxes, and interest of 486.87 B.

About Lixil Group Valuation

Our relative valuation model uses a comparative analysis of Lixil Group. We calculate exposure to Lixil Group's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Lixil Group's related companies.
LIXIL Corporation, through its subsidiaries, manufactures and sells building materials and housing equipment worldwide. LIXIL Corporation was founded in 1875 and is headquartered in Tokyo, Japan. Lixil Corp is traded on OTC Exchange in the United States.

8 Steps to conduct Lixil Group's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Lixil Group's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Lixil Group's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Lixil Group's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Lixil Group's revenue streams: Identify Lixil Group's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Lixil Group's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Lixil Group's growth potential: Evaluate Lixil Group's management, business model, and growth potential.
  • Determine Lixil Group's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Lixil Group's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Lixil Group Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding153.4 M
Quarterly Earnings Growth Y O Y-0.507
Retained Earnings267.9 B

Additional Tools for Lixil Pink Sheet Analysis

When running Lixil Group's price analysis, check to measure Lixil Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lixil Group is operating at the current time. Most of Lixil Group's value examination focuses on studying past and present price action to predict the probability of Lixil Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lixil Group's price. Additionally, you may evaluate how the addition of Lixil Group to your portfolios can decrease your overall portfolio volatility.